GLP-1 Side Effects: What to Expect and When to Call
Most GLP-1 side effects are digestive and ease with time. Learn what is common, how protein and hydration help, and which warning signs from the semaglutide and tirzepatide labels need prompt care.
The most common GLP-1 side effects are digestive: nausea, diarrhea, constipation, vomiting, stomach discomfort and reflux. They usually show up when you start or after a dose increase, and for most people they ease as the body adjusts. A few rarer problems listed on the semaglutide and tirzepatide labels, such as pancreatitis and gallbladder disease, need prompt medical attention, so it helps to know the signs before you begin.
Key takeaways
- Digestive effects are the most common and are usually mild to moderate. Gradual dose increases set by your provider help your body adapt.
- Small meals, protein first, plenty of fluids and less greasy food make a real difference.
- Dehydration from vomiting or diarrhea can strain the kidneys. Hydration is part of the plan, not an extra.
- Seek care right away for severe stomach pain that does not go away, signs of a gallbladder problem, or signs of an allergic reaction.
- Both labels carry a boxed warning about thyroid C-cell tumors seen in rodents. They are not used by people with a personal or family history of medullary thyroid carcinoma or MEN 2.
Common side effects and why they happen
GLP-1 medications slow how quickly your stomach empties and turn down appetite signals. That is part of how they help you eat less. It is also why your gut may need time to catch up.
The labels for brand semaglutide (Wegovy) and brand tirzepatide (Zepbound) list these among the most common effects:
| Side effect | What it often feels like | What usually helps |
|---|---|---|
| Nausea | Queasy after eating, especially large or rich meals | Smaller portions, eat slowly, stop at the first sign of fullness |
| Diarrhea | Loose stools in the first weeks | Fluids with electrolytes, simple foods, avoid very greasy meals |
| Constipation | Fewer bowel movements | Water, fiber from vegetables and fruit, daily movement |
| Vomiting | Usually after overeating | Smaller meals, pause eating, call your provider if it continues |
| Reflux and burping | Heartburn, sour taste | Avoid lying down after meals, limit late-night eating |
| Fatigue | Lower energy early on | Enough protein and calories, steady sleep |
| Injection-site reaction | Mild redness or itch | Rotate sites |
Hair shedding is also listed on both labels. It can happen with any significant change in body weight or eating, and it is worth mentioning to your provider so they can review your nutrition.
Fuel the body you are building
A lower appetite is helpful, but your body still needs enough nutrients to keep muscle and recover from training. A 2025 joint advisory from four nutrition and obesity medicine organizations recommends that people on GLP-1 medications prioritize enough protein and pair it with strength training to help preserve muscle and bone.
Practical moves that help both side effects and results:
- Protein first. Start each meal with lean protein such as eggs, fish, poultry, Greek yogurt, cottage cheese, tofu or beans. Use the protein target tool for a personal starting number.
- Small, regular meals. Long gaps followed by big plates often trigger nausea.
- Easy options on low-appetite days. Smoothies with yogurt or milk, soups and protein drinks are often easier than heavy meals.
- Fluids all day. Sip water steadily. Add electrolytes if you have diarrhea, vomiting or heavy sweating, which is common in South Florida heat.
- Go easy on alcohol and greasy food. Both commonly worsen nausea and reflux.
- Ginger or peppermint tea. The advisory lists these among simple options some people find soothing.
- Lift. Regular resistance training supports muscle while you reduce weight.
Serious warnings from the labels
These are less common, but your provider screens for them and you should know the signs.
Thyroid C-cell tumors (boxed warning). Semaglutide and tirzepatide caused thyroid C-cell tumors in rodents. It is not known whether this happens in people. These medications are not used if you or a family member has had medullary thyroid carcinoma, or if you have MEN 2. Tell your provider about a lump or swelling in your neck, trouble swallowing, shortness of breath or hoarseness that does not go away.
Pancreatitis. Inflammation of the pancreas has been reported. The warning sign is severe stomach pain that does not go away, sometimes spreading to the back, with or without vomiting. Stop the medication and get medical care right away if this happens.
Gallbladder problems. Gallstones and gallbladder inflammation have been reported, especially with larger or faster weight reduction. Signs include pain in the upper right or middle stomach, fever, yellowing of the skin or eyes, or clay-colored stools.
Kidney problems. Acute kidney injury has occurred, mostly in people who became dehydrated from digestive side effects. Keep fluids up and call your provider if you cannot keep liquids down.
Low blood sugar. The risk is higher if you also use insulin or a sulfonylurea. Signs include shakiness, sweating, confusion and a fast heartbeat.
Allergic reactions. Swelling of the face, lips, tongue or throat, trouble breathing or a severe rash needs emergency care.
Other label warnings. Faster resting heart rate, worsening diabetic eye disease in people with type 2 diabetes, and a risk of inhaling stomach contents during anesthesia or deep sedation. Tell any surgical or procedure team that you use a GLP-1 medication. The labels also say these drugs are not recommended for people with severe gastroparesis.
Birth control pills and tirzepatide. The tirzepatide label says it can make oral contraceptives less effective. It advises a non-oral method or a backup barrier method for 4 weeks after starting and after each dose increase.
Safe handling for compounded medications
The FDA has received reports of people getting sick after measuring the wrong amount from compounded GLP-1 vials. Your RULE program uses a compounded medication, which is not FDA-approved, so careful handling matters:
- Follow the exact instructions from your provider and pharmacy. Ask if anything is unclear.
- Use a new sterile needle and syringe every time.
- Do not use a product that arrives warm or without proper cold packaging.
- The FDA advises discarding a multi-dose vial 28 days after first use, even if medication remains, unless your pharmacy label says otherwise.
When to call
Message your provider if nausea, diarrhea or constipation lasts more than a few days, keeps you from eating or drinking, or makes it hard to train or work. Your provider may adjust your dose or timing.
Get urgent care for severe stomach pain that does not go away, vomiting you cannot stop, signs of dehydration such as very little urine or dizziness, yellowing skin or eyes, or a fast heartbeat at rest.
Call 911 for trouble breathing, swelling of the face or throat, or fainting.
Frequently asked questions
How long do GLP-1 side effects last?
For many people, digestive effects are strongest in the first weeks and after each dose increase, then settle. Everyone is different. If symptoms do not improve, your provider can slow the dose increase or adjust your plan.
Should I eat if I am not hungry?
Yes, in small amounts. Your body still needs protein, fluids and nutrients to keep muscle and energy. Small protein-forward meals at regular times work better than skipping meals and eating one large plate.
Can I keep training hard on a GLP-1 medication?
Most people can, and strength training is encouraged. Fuel before workouts, hydrate well and scale intensity on days you feel low. Tell your provider if you feel faint or unusually weak.
Are side effects different with compounded versions?
The active ingredient is the same, but compounded versions are not FDA-approved and have not been studied in the same trials. Measuring the correct amount is especially important with vials. Follow your pharmacy instructions closely.
Talk to a licensed provider
If you are considering a GLP-1 program or want help managing side effects, start a secure online visit. A licensed provider will review your health history, talk through what to expect and decide whether a prescription is appropriate for you.
Sources
- FDA label via DailyMed, Wegovy (semaglutide) prescribing information
- FDA label via DailyMed, Zepbound (tirzepatide) prescribing information
- MedlinePlus, Semaglutide Injection
- MedlinePlus, Tirzepatide Injection
- MedlinePlus Medical Encyclopedia, GLP-1 agonists
- Mozaffarian D et al., Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory (PubMed)
- FDA, FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Reviewed October 28, 2026.
This article is educational and is not medical advice. Rx programs require an online visit with a licensed provider. Results vary.
